search
Back to results

Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing (Avoid FFS)

Primary Purpose

Atrial Fibrillation, Bradycardia

Status
Completed
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
pacemaker implantation
Sponsored by
Abbott Medical Devices
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Atrial Fibrillation focused on measuring Farfield Sensing, Pacing lead, Postventricular atrial blanking, Bradycardia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Indication for dual chamber pacing
  • Implantation of an Identity (ADX) DR or Victory or later pacemaker (St. Jude Medical)
  • Bipolar atrial pacing electrode
  • Age >= 18 years

Exclusion Criteria:

  • Persistent / permanent Atrial Arrhythmia
  • Pacemaker Revision
  • Pregnancy
  • Participation in another Study involving active implantable medical devices
  • Unable to complete follow up
  • Missing patient informed consent
  • Cardiac surgery or myocardial infarction within the last 4 weeks
  • Planned cardiac surgery within 3 months after enrollment

Sites / Locations

  • Klinikum Coburg
  • Klinik Fränkische Schweiz
  • Kreisklinik Ebersberg
  • Krankenhaus Waltershausen-Friedrichroda
  • Universitäres Herzzentrum Hamburg
  • Klinikum Memmingen
  • Deutsches Herzzentrum Muenchen
  • Kardiologische Praxis Dres. med. Bödigheimer / Mühling / Prof. Dr. med. Silber
  • Kreiskrankenhaus Ottweiler
  • Universitätsklinikum Ulm

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1699T (Optisense)

Standard lead

Arm Description

Implantation of the Optisense Lead 1699T, programming of the shortest possible postventricular atrial blanking period (PVAB)

Implantation of a standard bipolar atrial pacing lead. Optimization of the postventricular atrial blanking period (PVAB) after implantation.

Outcomes

Primary Outcome Measures

Incidence of inappropriate mode switch (documented by stored EGM's) using the atrial lead Tendril 1699T with short post ventricular atrial blanking period (PVAB) compared to standard atrial lead (Tentril 1388 or 1688) with optimised PVAB

Secondary Outcome Measures

Incidence of inappropriate mode switch in respect to lead position and ventricular stimulation frequency
Atrial Flutter in stored EGM's
2:1 lock in of Atrial Flutter

Full Information

First Posted
August 7, 2007
Last Updated
February 1, 2019
Sponsor
Abbott Medical Devices
search

1. Study Identification

Unique Protocol Identification Number
NCT00512915
Brief Title
Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing
Acronym
Avoid FFS
Official Title
Atriale Vorhofsonde 1699 Mit Sehr Kurzem Bipolabstand Zur Vermeidung Von Far Field Sensing
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
December 2006 (undefined)
Primary Completion Date
May 2008 (Actual)
Study Completion Date
August 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Abbott Medical Devices

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the possibility to program the shortest possible Post Ventricular Atrial Blanking Period (PVAB) and high sensitivity without getting inappropriate Mode Switch due to Far Field R-Wave sensing when using the new Tendril 1699T lead. Comparison with Tendril 1688T or 1388T with optimized Post Ventricular Atrial Blanking (PVAB).
Detailed Description
Far-field R-wave sensing (FFS) in the atrial channel of dual chamber pacemakers is a relevant source for inappropriate Mode Switch from the DDD mode to the DDI or VDI mode. Inappropriate loss of atrioventricular synchrony due to false positive Mode Switch is hemodynamically disadvantageous, may induce atrial tachyarrhythmias, can lead to pacemaker syndrome, and impairs the reliability of pacemaker Holter data. The aim of the study is to determine whether the use of a new atrial screw in lead with ultra short tip-ring distance of 1.1 mm (Study Group) eliminates the need for individual adjustment of the postventricular atrial blanking period (PVAB) based on an additional test in the Control Group with standard leads.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Bradycardia
Keywords
Farfield Sensing, Pacing lead, Postventricular atrial blanking, Bradycardia

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
204 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1699T (Optisense)
Arm Type
Active Comparator
Arm Description
Implantation of the Optisense Lead 1699T, programming of the shortest possible postventricular atrial blanking period (PVAB)
Arm Title
Standard lead
Arm Type
Active Comparator
Arm Description
Implantation of a standard bipolar atrial pacing lead. Optimization of the postventricular atrial blanking period (PVAB) after implantation.
Intervention Type
Device
Intervention Name(s)
pacemaker implantation
Other Intervention Name(s)
Active Arm: 1699T Tendril Optisense lead, Standard lead: 1688T Tendril SDX, 1788T Tendril ST, 1888T Tendril ST OPTIM
Intervention Description
St. Jude Medical Dual Chamber Pacemaker model Identity (ADx) DR, Victory DR, or newer
Primary Outcome Measure Information:
Title
Incidence of inappropriate mode switch (documented by stored EGM's) using the atrial lead Tendril 1699T with short post ventricular atrial blanking period (PVAB) compared to standard atrial lead (Tentril 1388 or 1688) with optimised PVAB
Time Frame
1 and 3 months post implantation
Secondary Outcome Measure Information:
Title
Incidence of inappropriate mode switch in respect to lead position and ventricular stimulation frequency
Time Frame
1 and 3 months post implantation
Title
Atrial Flutter in stored EGM's
Time Frame
1 and 3 months post implantation
Title
2:1 lock in of Atrial Flutter
Time Frame
1 and 3 months post implantation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Indication for dual chamber pacing Implantation of an Identity (ADX) DR or Victory or later pacemaker (St. Jude Medical) Bipolar atrial pacing electrode Age >= 18 years Exclusion Criteria: Persistent / permanent Atrial Arrhythmia Pacemaker Revision Pregnancy Participation in another Study involving active implantable medical devices Unable to complete follow up Missing patient informed consent Cardiac surgery or myocardial infarction within the last 4 weeks Planned cardiac surgery within 3 months after enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christof Kolb, MD
Organizational Affiliation
Deutsches Herzzentrum Muenchen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Klinikum Coburg
City
Coburg
ZIP/Postal Code
96450
Country
Germany
Facility Name
Klinik Fränkische Schweiz
City
Ebermannstadt
ZIP/Postal Code
91320
Country
Germany
Facility Name
Kreisklinik Ebersberg
City
Ebersberg
ZIP/Postal Code
85560
Country
Germany
Facility Name
Krankenhaus Waltershausen-Friedrichroda
City
Friedrichroda
ZIP/Postal Code
99894
Country
Germany
Facility Name
Universitäres Herzzentrum Hamburg
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Facility Name
Klinikum Memmingen
City
Memmingen
ZIP/Postal Code
87700
Country
Germany
Facility Name
Deutsches Herzzentrum Muenchen
City
Munich
ZIP/Postal Code
80636
Country
Germany
Facility Name
Kardiologische Praxis Dres. med. Bödigheimer / Mühling / Prof. Dr. med. Silber
City
München
ZIP/Postal Code
80331
Country
Germany
Facility Name
Kreiskrankenhaus Ottweiler
City
Ottweiler
ZIP/Postal Code
66564
Country
Germany
Facility Name
Universitätsklinikum Ulm
City
Ulm
ZIP/Postal Code
89081
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
22745661
Citation
Kolb C, Nolker G, Lennerz C, Jetter H, Semmler V, Purner K, Gutleben KJ, Reents T, Lang K, Lotze U; AVOID-FFS Investigators. Use of an atrial lead with very short tip-to-ring spacing avoids oversensing of far-field R-wave. PLoS One. 2012;7(6):e38277. doi: 10.1371/journal.pone.0038277. Epub 2012 Jun 22.
Results Reference
derived

Learn more about this trial

Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing

We'll reach out to this number within 24 hrs